Natriuretic peptide levels taken following unplanned admission to a cardiology department predict the duration of hospitalization (Q48582357)

13 February 2018

title

Natriuretic peptide levels taken following unplanned admission to a cardiology department predict the duration of hospitalization (English)

1 reference

13 February 2018

1 reference

Kenneth Dickstein

1 reference

13 February 2018

author name string

Marte Asphaug

series ordinal

1 reference

13 February 2018

Øyvind Skadberg

series ordinal

1 reference

13 February 2018

Ingvild Dalen

series ordinal

1 reference

13 February 2018

publication date

9 August 2016

1 reference

13 February 2018

European Journal of Heart Failure

published in

1 reference

13 February 2018

volume

1 reference

13 February 2018

issue

1 reference

13 February 2018

page(s)

1499-1505

1 reference

13 February 2018

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

cites work

1 reference

The annual global economic burden of heart failure

21 January 2018

1 reference

Scope of heart failure hospitalization

21 January 2018

1 reference

Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine

21 January 2018

1 reference

Natriuretic peptide-guided heart failure management

21 January 2018

1 reference

The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.

21 January 2018

1 reference

Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors

21 January 2018

1 reference

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure

21 January 2018

1 reference

Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial

21 January 2018

1 reference

Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

21 January 2018

1 reference

N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure

21 January 2018

1 reference

Clinical applications of B-type natriuretic peptide (BNP) testing.

21 January 2018

1 reference

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study

21 January 2018

1 reference

Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.

21 January 2018

1 reference

Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials

21 January 2018

1 reference

B-type natriuretic peptide-guided heart failure therapy: A meta-analysis

21 January 2018

1 reference

Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials

21 January 2018

1 reference

Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review

21 January 2018

1 reference

Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure

21 January 2018

1 reference

Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease

21 January 2018

1 reference

Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure

21 January 2018

1 reference

B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea: a randomized trial

21 January 2018

1 reference

N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome

21 January 2018

1 reference

Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department

21 January 2018

1 reference

Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea

21 January 2018

1 reference

Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study

21 January 2018

1 reference

Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism

21 January 2018

1 reference

B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction

21 January 2018

1 reference

What are the costs of heart failure?

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/EJHF.604

1 reference

13 February 2018

1 reference

13 February 2018